Skip to Main Content

ASTHMA

The guidelines of the 2019 Global Strategy for Asthma Management and Prevention Report cover (1) assessing asthma control and severity, (2) distinguishing between severe asthma and uncontrolled asthma, (3) personalized pharmacologic therapy for asthma, (4) treatment of modifiable risk factors and control of environmental factors, and (5) guided self-management education and skills training.

E-CIGARETTE OR VAPING PRODUCT ASSOCIATED LUNG INJURY (EVALI)

Diagnosis of EVALI requires reported use of e-cigarette or vaping products within 3 months of symptom onset, compatible chest imaging findings (bilateral pulmonary opacities on chest radiograph, CT findings similar to hypersensitivity pneumonitis, acute respiratory distress syndrome, diffuse alveolar hemorrhage, acute eosinophilic pneumonia, lipoid pneumonia, giant cell interstitial pneumonia, and organizing pneumonia), and an evaluation to exclude infectious etiologies.

In hospitalized patients with EVALI, rapid improvement with corticosteroids has been described.

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.